2025年美国IPO市场回顾：371只新股上市 覆盖全球20个国家和地区 中国居首

Group 1 - The US IPO market demonstrated strong momentum in 2025, with 371 new stocks listed and a total fundraising amount of $69.764 billion, representing year-on-year increases of 55.23% and 81.53% respectively [1] - Among the 371 new stocks, 145 were SPAC IPOs, raising a total of $26.579 billion, with year-on-year growth of 154.39% and 321.36% [1] - Nasdaq continued to dominate the new stock flow, attracting 80% of new listings and accounting for 67.56% of the total fundraising amount [4] Group 2 - The distribution of fundraising amounts showed that 38% of new stocks raised between $100 million and $300 million, while 23% raised less than $10 million, and only 3% raised over $1 billion, indicating a balanced support for both small and leading enterprises [5] - The top ten fundraising companies included Medline ($6.265 billion), Venture Global ($1.75 billion), and CoreWeave ($1.5 billion), showcasing a diverse range of sectors [7] - The new stock sources exhibited a global characteristic, with Chinese companies contributing nearly 25% of the total new stock quantity, followed by Singapore at 7% [7] Group 3 - The technology and healthcare sectors led the IPO trends, with application software, biopharmaceuticals, and data processing contributing over a quarter of the new stock quantity, reflecting a shift towards high-growth, technology-intensive industries [9] - The significant increase in the number and amount of fundraising in the US stock market in 2025 was driven by active SPACs, the strengthening of Nasdaq's platform effect, and the availability of international listing channels [9]